ModeX Therapeutics, An OPKO Health Company
4 clinical trials · Sponsor
◉ Watch ModeX Therapeutics, An OPKO Health Company
| Record | Firm | Date |
|---|---|---|
| Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma (NCT07249905) | ModeX Therapeutics, An OPKO Health Company | 2026-04-13 |
| A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19. (NCT07445971) | ModeX Therapeutics, An OPKO Health Company | 2026-03-24 |
| Dose Escalation and Dose Expansion Study of MDX2004 in Participants With Advanced Tumors (NCT07110584) | ModeX Therapeutics, An OPKO Health Company | 2025-10-01 |
| Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors (NCT06239194) | ModeX Therapeutics, An OPKO Health Company | 2024-06-12 |
Track ModeX Therapeutics, An OPKO Health Company automatically
Every clearance here is in the API, with alerts when new ones post.